Close Menu

Over at evolgen, the blogger who goes by RPM links to a video interview with Michael Ashburner hosted by BioMed Central. In the interview, Ashburner is "espousing the virtues of open access," writes RPM, noting that the highly regarded scientist "also walks the walk, proclaiming that he will not publish in non-open access journal, nor review articles for non-open access journals."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.